Report Highlights
The global life science tools and diagnostics market should reach $87.3 billion by 2025 from $82.2 billion in 2020 at a compound annual growth rate (CAGR) of 7.7% for the forecast period of 2019 to 2025.
Report Includes
- 95 data tables and 21 additional tables
- An overview of the global market for life science tools and diagnostics
- Estimation of the market size and analyses of market trends, with data from 2018, 2019, 2020, and projections of compound annual growth rates (CAGRs) through 2025
- Discussion on how scientific trends, government policies, and the economy in general affect life science tools and diagnostics market and how this industry is different from the pharmaceutical and drug discovery industry
- Assessment of existing products and identification of new potential markets for novel products and assay development
- Detailed description about COVID-19, including disease progression, symptoms and treatment options and impact analysis of COVID-19 on entire life science industry as well as on life science tools and diagnostics industry
- Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market trends, market size, market forecast, and technological advancements within the industry
- Comprehensive company profiles of the leading players, including Abbott Laboratories, Bio-Rad Laboratories, General Electric Co., Merck & Co. Inc., Qiagen NV, and Siemens Healthcare AG
Report Scope
The current report provides a detailed look at the life science tools and diagnostics market. This report also highlights the current and future market potential of life science tools and diagnostics, along with a detailed analysis of the competitive environment, regulatory scenario, technological advances, and drivers, restraints, opportunities and trends in the market. The report also covers market projections to 2025. The report details the market share of life science tools and diagnostics.
By geographical region, the market has been segregated into North America, Europe, Asia-Pacific, and the Rest of the world (RoW). The North America region includes the U.S., Canada and Mexico; Europe includes Germany, the U.K., France, Italy, Spain and the Rest of Europe. The Asia-Pacific region includes China, India, Japan, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2018 as the base year, 2019 and forecast for 2025.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Molecular Farming: Global Markets (CHM187A)
- Exosome Diagnostics, Therapeutics and Research Tools: Global Markets (BIO149E)
- Global Skin Allergy Testing Market (MDS104A)
- Global Aircraft Recycling Market (AVM250A)
- Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets (HLC078F)
Report Highlights
The global market for life sciences tools and reagents reached $45.9 billion in 2014 and $48.2 billion in 2015. The market should reach $58.0 billion by 2020, growing at a compound annual growth rate (CAGR) of 3.8% from 2015 to 2020.
Report Includes
- An overview of the global market for life science tools and reagents.
- Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Identification of existing products as well as new potential markets for novel products and assay development.
- Discussion of how scientific trends, government policies, and the economy in general affect this industrial market as compared to pharmaceutical and drug discovery ventures; for example, the launches of new reagents or products is not affected by strict FDA guidelines.
- Examination of drivers and challenges in each segment of the industry.
- Relevant patent analysis.
- Comprehensive company profiles of major players in the market.
Report Highlights
The global market for life science tools and reagents reached $47.8 billion in 2012. This figure is expected to increase to $51.3 billion in 2013 and $77.6 billion in 2018, with a projected five-year compound annual growth rate (CAGR) of 8.6%.
Report Includes
- An overview of the global market for life science tools and reagents.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Identification of existing products as well as new potential markets for novel products and assay development.
- Discussion of how scientific trends, government policies, and the economy in general affect this industrial market as compared to pharmaceutical and drug discovery ventures; for example, the launches of new reagents or products is not affected by strict FDA guidelines.
- Examination of drivers and challenges in each segment of the industry.
- Patent analysis.
- Comprehensive company profiles of major players in the market.
Report Highlights
The life science tools market has shown steady growth over the last couple of years despite the economic downturn. This market is currently valued at more than $42 billion and is projected to increase at compound annual growth rate (CAGR) of 13.6% to reach approximately $81 billion in 2016.
Related Reports
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.
Polymerase Chain Reaction (PCR) Technologies and Global Markets
The global market for polymerase chain reaction (PCR) is estimated to increase from $9.1 billion in 2023 to reach $12.6 billion by 2028, at a compound annual growth rate (CAGR) of 6.7% from 2023 through 2028.
Western Blotting: Global Markets
The global market for western blotting is expected to grow from $1.5 billion in 2023 to over $2.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% during the forecast period of 2023-2028.
Bioinformatics: Technologies and Global Markets
The global market for bioinformatics is expected to grow from $18.7 billion in 2023 to $35.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 13.6% during the forecast period of 2023-2028.
Recent Reports
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Viral Vector and Plasmid DNA: Technologies and Global Markets
The global market for viral vector and plasmid DNA technologies is expected to grow from $2.9 billion in 2023 to $7.1 billion by the end of 2028, at a compound annual growth rate (CAGR) of 19.7% from 2023 through 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
Flame Retardant Chemicals: Technologies and Global Markets
The global consumption of flame retardant chemicals is estimated to grow from 6.0 billion pounds in 2022 to 7.5 billion pounds in 2027, at a compound annual growth rate (CAGR) of 4.4% for the period of 2022-2027.
Biorefinery Products: Global Markets
The global market for biorefinery products is estimated to increase from $624.7 billion in 2022 to $920.0 billion by 2027, at a compound annual growth rate (CAGR) of 8.0% from 2022 through 2027.
Electric Vehicle Charging: Infrastructure and Global Markets
The global market for wired electric vehicle charging infrastructure is estimated to grow from $24.1 billion in 2022 to $81.1 billion in 2027, at a compound annual growth rate (CAGR) of 27.4% for the period of 2022-2027.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More